Glaxosmithkline Pharma trades in green on the BSE

16 Sep 2022 Evaluate

Glaxosmithkline Pharmaceuticals is currently trading at Rs. 1407.65, up by 2.35 points or 0.17% from its previous closing of Rs. 1405.30 on the BSE.

The scrip opened at Rs. 1405.00 and has touched a high and low of Rs. 1415.20 and Rs. 1404.00 respectively. So far 1190 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1917.00 on 13-Dec-2021 and a 52 week low of Rs. 1372.80 on 04-Aug-2022.

Last one week high and low of the scrip stood at Rs. 1440.65 and Rs. 1400.00 respectively. The current market cap of the company is Rs. 23872.70 crore.

The promoters holding in the company stood at 75.00%, while Institutions and Non-Institutions held 12.81% and 12.19% respectively.

Life Insurance Corporation of India (LIC) had offloaded 34.63 lakh equity shares or 2.04 percent stake in Glaxosmithkline Pharmaceuticals via open market transactions. With this, LIC's shareholding in the company reduced to 4.35 percent, down from 6.4 percent earlier.

GlaxoSmithKline Pharmaceuticals is an Indian subsidiary of GlaxoSmithKline plc. The company business has a broad portfolio of innovative and established medicines, with leadership positions in respiratory and HIV.

Glaxosmithkline Phar Share Price

2311.50 -68.35 (-2.87%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×